======= PLAGL2 =======
== Gene Information ==
* **Official Symbol**: PLAGL2
* **Official Name**: PLAG1 like zinc finger 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5326|5326]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UPG8|Q9UPG8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PLAGL2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLAGL2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604866|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Shows weak transcriptional activatory activity.
No Pfam Domain information is available for this gene.
|chylomicron assembly|
|plasma lipoprotein particle assembly|
|protein-lipid complex assembly|
|plasma lipoprotein particle organization|
|protein-lipid complex subunit organization|
|positive regulation of intrinsic apoptotic signaling pathway|
|regulation of plasma lipoprotein particle levels|
|post-embryonic development|
|regulation of intrinsic apoptotic signaling pathway|
|positive regulation of apoptotic signaling pathway|
|extracellular structure organization|
|regulation of apoptotic signaling pathway|
|sequence-specific DNA binding|
|DNA-binding transcription activator activity, RNA polymerase II-specific|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|positive regulation of apoptotic process|
|positive regulation of programmed cell death|
|RNA biosynthetic process|
|DNA-binding transcription factor activity|
|positive regulation of cell death|
|positive regulation of intracellular signal transduction|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|lipid metabolic process|
|positive regulation of transcription by RNA polymerase II|
|organic cyclic compound biosynthetic process|
|regulation of apoptotic process|
|positive regulation of transcription, DNA-templated|
|protein-containing complex assembly|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|regulation of programmed cell death|
|cellular nitrogen compound biosynthetic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of signal transduction|
|RNA metabolic process|
|regulation of cell death|
|cellular macromolecule biosynthetic process|
|positive regulation of RNA metabolic process|
|macromolecule biosynthetic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
|protein-containing complex subunit organization|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|1.7|
|[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|1.73|
|[[:results:exp492|iCRT14 30μM R08 exp492]]|1.79|
|[[:results:exp116|AICAR 240μM R03 exp116]]|1.8|
|[[:results:exp240|Pyridostatin 4μM R05 exp240]]|2.08|
^Gene^Correlation^
|[[:human genes:g:gnas|GNAS]]|0.405|
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|1/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6654
* **Expression level (log2 read counts)**: 5.77
{{:chemogenomics:nalm6 dist.png?nolink |}}